DE2633976A1 - Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel - Google Patents

Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel

Info

Publication number
DE2633976A1
DE2633976A1 DE19762633976 DE2633976A DE2633976A1 DE 2633976 A1 DE2633976 A1 DE 2633976A1 DE 19762633976 DE19762633976 DE 19762633976 DE 2633976 A DE2633976 A DE 2633976A DE 2633976 A1 DE2633976 A1 DE 2633976A1
Authority
DE
Germany
Prior art keywords
formula
amino
tripeptide
pro
alkylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19762633976
Other languages
German (de)
English (en)
Inventor
Amedeo Failli
Manfred Karl Goetz
Hans Ueli Immer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Canada Inc
Original Assignee
Ayerst Mckenna and Harrison Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna and Harrison Inc filed Critical Ayerst Mckenna and Harrison Inc
Publication of DE2633976A1 publication Critical patent/DE2633976A1/de
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE19762633976 1975-07-28 1976-07-28 Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel Ceased DE2633976A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/599,450 US4018912A (en) 1975-07-28 1975-07-28 Tripeptide derivatives with central nervous system activity and preparation thereof

Publications (1)

Publication Number Publication Date
DE2633976A1 true DE2633976A1 (de) 1977-02-10

Family

ID=24399667

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762633976 Ceased DE2633976A1 (de) 1975-07-28 1976-07-28 Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel

Country Status (10)

Country Link
US (1) US4018912A (US07935154-20110503-C00006.png)
JP (1) JPS6033854B2 (US07935154-20110503-C00006.png)
BE (1) BE844603A (US07935154-20110503-C00006.png)
CA (1) CA1062250A (US07935154-20110503-C00006.png)
CH (1) CH621111A5 (US07935154-20110503-C00006.png)
DE (1) DE2633976A1 (US07935154-20110503-C00006.png)
FR (1) FR2319378A1 (US07935154-20110503-C00006.png)
GB (1) GB1523685A (US07935154-20110503-C00006.png)
SE (2) SE431330B (US07935154-20110503-C00006.png)
SU (1) SU632299A3 (US07935154-20110503-C00006.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093713A (en) * 1977-02-28 1978-06-06 Ayerst Mckenna & Harrison Ltd. Dipeptide derivatives with central nervous system activity and preparation thereof
DE3226242A1 (de) * 1982-07-14 1984-01-26 Basf Ag, 6700 Ludwigshafen N-acylderivate von dipeptiden, ihre herstellung und verwendung bei der therapie von krankheiten und mittel dafuer
DE3226241A1 (de) * 1982-07-14 1984-01-26 Basf Ag, 6700 Ludwigshafen N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer
US5190924A (en) * 1991-02-13 1993-03-02 Boc Health Care, Inc. Peptide amides and amide dimers useful as muscle relaxants
US6767897B2 (en) * 1994-05-04 2004-07-27 Innapharma, Inc. Therapeutic uses of tri-, tetra-, penta-, and polypeptides
US5589460A (en) * 1994-05-04 1996-12-31 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US5767083A (en) * 1994-05-04 1998-06-16 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US6489300B1 (en) * 1997-07-31 2002-12-03 Eugene D. Thorsett Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
DE19813849A1 (de) * 1998-03-27 1999-09-30 Degussa Verfahren zur einstufigen Umsalzung und Aufreinigung von Oligopeptiden

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1033905A (en) * 1962-03-30 1966-06-22 Geigy Ag J R Process for the production of a new pentapeptide
NL6707845A (US07935154-20110503-C00006.png) * 1966-06-11 1967-12-12
BE787908A (fr) * 1971-08-24 1973-02-23 Abbott Lab Medicament antidepressif et antiparkinsonien
US3888840A (en) * 1973-02-07 1975-06-10 American Home Prod Novel hydrazinocarboxamide derivatives and preparation thereof

Also Published As

Publication number Publication date
SE431330B (sv) 1984-01-30
GB1523685A (en) 1978-09-06
US4018912A (en) 1977-04-19
JPS6033854B2 (ja) 1985-08-05
CA1062250A (en) 1979-09-11
SE8006119L (sv) 1980-09-02
FR2319378B1 (US07935154-20110503-C00006.png) 1979-05-04
JPS5223070A (en) 1977-02-21
CH621111A5 (US07935154-20110503-C00006.png) 1981-01-15
FR2319378A1 (fr) 1977-02-25
SU632299A3 (ru) 1978-11-05
BE844603A (fr) 1977-01-28

Similar Documents

Publication Publication Date Title
EP0871653B1 (de) Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE2514381C3 (de) Tripeptide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
CH629475A5 (de) Verfahren zur herstellung von polypeptiden.
DE3100974A1 (de) Thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente enthaltende arzneimittel mit immunregulierender wirkung, und thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente
DE69219590T2 (de) BPC-Peptide, deren Herstellung und Verwendung
DD217807A5 (de) Verfahren zur herstellung neuer substituierter tetrapeptide
CH644352A5 (en) Process for the preparation of peptides
DE69217763T2 (de) Hexapeptide
DE2633976A1 (de) Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE2635558A1 (de) Somatostatinanaloge
CH676425A5 (US07935154-20110503-C00006.png)
DE2544348A1 (de) L-leucin-13-motilin, verfahren zu dessen herstellung und dasselbe enthaltendes mittel
DE1543872C3 (de) D Ser hoch 1 Nie hoch 4 Pentacosapeptid sowie Verfahren zu dessen Herstellung
DE1518133B1 (de) Verfahren zur Herstellung eines neuen hypotensiv wirkenden Hendekapeptids
CH623026A5 (US07935154-20110503-C00006.png)
DE69425734T2 (de) Aureobasidine
DE1248059B (de) Verfahren zur Herstellung bradykininwirksamer Undeca- und Dodecapeptide
DE2532823A1 (de) Neue polypeptide
DE2901478A1 (de) Beta tief h -endorphin-analoge und deren herstellung
EP0203450B1 (de) Neue Derivate bicyclischer Aminosäuren, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
EP0069894B1 (de) Optisch aktives Dipeptide, seine pharmazeutisch verträglichen Salze, Verfahren zur Herstellung und diese enthaltende pharmazeutische Präparate
DE1518343A1 (de) Verfahren zur Herstellung eledoisinwirksamer Undekapeptide
DE68913936T2 (de) Retro-Inverso-Thrymopentin-Analoge, Verfahren zu deren Herstellung und deren Verwendung für die Zubereitung von pharmazeutischen Zusammensetzungen.
DD296084A5 (de) Verfahren zur herstellung von humanen spleninderivaten
DE69316974T2 (de) Bpc-peptide, deren herstellung und therapeutischen verwendung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection